Australia - English - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - terbutaline sulfate, quantity: 400 microgram/actuation - inhalation, powder for - excipient ingredients: lactose monohydrate - for relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma or in other situations known to induce bronchospasm.,bricanyl turbuhaler is intended for short-term management of bronchospasm.

New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - terbutaline sulfate 0.25mg; terbutaline sulfate 200ug equivalent to 0.25 mg metered dose - powder for inhalation - 0.25 mg/dose - active: terbutaline sulfate 0.25mg terbutaline sulfate 200ug equivalent to 0.25 mg metered dose excipient: lactose monohydrate - relief of bronchospasm occurring in bronchial asthma, bronchitis and other bronchopulmonary conditions where bronchospasm is a complicating factor. acute prophylaxis in situations known to induce bronchospasm, e.g. exercise induced asthma.

New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - terbutaline sulfate 0.5mg - powder for inhalation - 0.5 mg/dose - active: terbutaline sulfate 0.5mg

Canada - English - Health Canada

astrazeneca canada inc - terbutaline sulfate - powder (metered dose) - 0.5mg - terbutaline sulfate 0.5mg - selective beta 2-adrenergic agonists

Australia - English - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - terbutaline sulfate, quantity: 0.5 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; water for injections - indications ast at 24 june 2004: for relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma or in other situations known to induce bronchospasm. bricanyl injection: bricanyl injection solution is recommended for acute use only.

Singapore - English - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - terbutaline sulphate - powder, metered - 0.5 mg/dose

Ireland - English - HPRA (Health Products Regulatory Authority)

astrazeneca uk limited - terbutaline sulfate - powder for inhalation - 500 mcg/acutuation - terbutaline

Australia - English - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - budesonide, quantity: 100 microgram/actuation - insufflation - excipient ingredients: - treatment of bronchial asthma. indications as at 3 june 1994: treatment of bronchial asthma. may also be used when replacement or reduction in oral steroid therapy is desired.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

astrazeneca uk ltd - terbutaline sulfate - inhalation powder - 500microgram/1dose

Australia - English - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - terbutaline sulfate, quantity: 0.5 mg/actuation - inhalation, powder for - excipient ingredients: - relief of bronchospasm occurring in bronchial asthma, bronchitis and other bronchopulmonary conditions where bronchospasm is a complicating factor. acute prophylaxis in conditions known to induce bronchospasm eg exercise induced asthma